AK

Ashish Kesharwani

Active Director Director DIN 09633016
DIN 09633016 First appointment Jun 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Ashish Kesharwani

Data last updated:

Ashish Kesharwani is a Director at Brionova Pharmaceutical Private Limited (since 2022). The company operates in Pharma. Brionova Pharmaceutical Private Limited reported revenue of ₹1.19 Cr (FY 2025).

DIN 09633016
Primary Designation Director
Industry Pharma
First Appointment 10 Jun 2022
Oldest Company Age 7 yrs
Largest company Brionova Pharmaceutical Private Limited · ₹1.19 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jun 20222019₹1.19 Cr (FY 2025)Active

Board colleagues of Ashish Kesharwani

Directorship timeline

Open interactive timeline →
Brionova Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Ashish Kesharwani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashish Kesharwani

Ashish Kesharwani currently holds 1 directorship: Brionova Pharmaceutical Private Limited (Director, since 10 Jun 2022, revenue ₹1.19 Cr (FY 2025)).

Ashish Kesharwani was first appointed on 10 Jun 2022 as Director at Brionova Pharmaceutical Private Limited.

The current boards of Ashish Kesharwani's companies include Manju Ashish Kesharwani (Brionova Pharmaceutical Private Limited), Neha Sahu (Brionova Pharmaceutical Private Limited), Sunil Sahu (Brionova Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available